Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 12, 2007, Pages 2195-2201

  Malyshev, Eugene ^a   Tazi, Khalid A ^a   Moreau, Richard ^a   Lebrec, Didier ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Aorta; Nitric oxide; Portal hypertension; Superior mesenteric artery; Vasodilation

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; LIPOPOLYSACCHARIDE; LYSINE DERIVATIVE; N IMINOETHYLLYSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; LIVER CIRRHOSIS; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW; UPREGULATION;

EID: 36348961205     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04608.x     Document Type: Article

References (32)

1. Sogni P, Sabry S, Moreau R, Gadano A, Lebrec D, Dinh-Xuan AT. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats. J. Hepatol. 1996 24 : 487 90.
2. Tazi KA, Barriere E, Moreau R et al. Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis. Gastroenterology 2002 122 : 1869 77.
3. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991 337 : 776 8.
4. Maher JJ. Cytokines: overview. Semin. Liver Dis. 1999 19 : 109 15.
5. Liu H, Song D, Lee SS. Increased nitric oxide synthase expression in aorta of cirrhotic rats. Life Sci. 1999 64 : 1753 9.
6. Heller J, Sogni P, Tazi KA et al. Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration. Hepatology 1999 30 : 698 704.
7. Pateron D, Tazi KA, Sogni P et al. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension. Gastroenterology 2000 119 : 196 200.
8. Lefilliatre P, Sogni P, Bertrand V et al. Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: beneficial effects of a non-steroidal anti-inflammatory drug coupled with a nitric oxide donor. J. Gastroenterol. Hepatol. 2001 16 : 70 8.
9. Morales-Ruiz M, Jimenez W, Ros J et al. Nitric oxide production by peritoneal macrophages of cirrhotic rats: a host response against bacterial peritonitis. Gastroenterology 1997 112 : 2056 64.
10. Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann RJ. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J. Clin. Invest. 1999 104 : 1223 33.
11. Gadano AC, Sogni P, Heller J, Moreau R, Bories PN, Lebrec D. Vascular nitric oxide production during the development of two experimental models of portal hypertension. J. Hepatol. 1999 30 : 896 903.
12. Wiest R, Shah V, Sessa WC, Groszmann RJ. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am. J. Physiol. 1999 276 : G1043 51.
13. Briones AM, Alonso MJ, Hernanz R, Tovar S, Vila E, Salaices M. Hypertension alters the participation of contractile prostanoids and superoxide anions in lipopolysaccharide effects on small mesenteric arteries. Life Sci. 2002 71 : 1997 2014.
14. Tsai MH, Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats. Gastroenterology 2003 125 : 1452 61.
15. Lee SS, Girod C, Braillon A, Hadengue A, Lebrec D. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. Am. J. Physiol. 1986 251 : G176 80.
16. Sogni P, Smith AP, Gadano A, Lebrec D, Higenbottam TW. Induction of nitric oxide synthase II does not account for excess vascular nitric oxide production in experimental cirrhosis. J. Hepatol. 1997 26 : 1120 7.
17. Schwartz D, Mendonca M, Schwartz I et al. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J. Clin. Invest. 1997 100 : 439 48.
18. Fischer LG, Horstman DJ, Hahnenkamp K, Kechner NE, Rich GF. Selective iNOS inhibition attenuates acetylcholine- and bradykinin-induced vasoconstriction in lipopolysaccharide-exposed rat lungs. Anesthesiology 1999 91 : 1724 32.
19. Vos TA, Van Goor H, Tuyt L et al. Expression of inducible nitric oxide synthase in endotoxemic rat hepatocytes is dependent on the cellular glutathione status. Hepatology 1999 29 : 421 6.
20. Assreuy J, Cunha FQ, Liew FY, Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br. J. Pharmacol. 1993 108 : 833 7.
21. Buga GM, Griscavage JM, Rogers NE, Ignarro JL. Negative feedback regulation of endothelial cell function by nitric oxide. Circ. Res. 1993 73 : 808 12.
22. Strunk V, Hahnenkamp K, Schneuing M, Fischer LG, Rich GF. Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation. Anesth. Analg. 2001 92 : 681 7.
23. Pulido EJ, Shames BD, Fullerton DA et al. Differential inducible nitric oxide synthase expression in systemic and pulmonary vessels after endotoxin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000 278 : 1232 9.
24. Park CS, Krishna G, Ahn MS et al. Differential and constitutive expression of neuronal, inducible, and endothelial nitric oxide synthase mRNAs and proteins in pathologically normal human tissues. Nitric Oxide 2000 4 : 459 71.
25. Kleschyov AL, Muller B, Keravis T, Stoeckel ME, Stoclet JC. Adventitia-derived nitric oxide in rat aortas exposed to endotoxin: cell origin and functional consequences. Am. J. Physiol. Heart. Circ. Physiol. 2000 279 : H2743 51.
26. De Meyer GR, Kockx MM, Cromheeke KM, Seye CI, Herman AG, Bult H. Periadventitial inducible nitric oxide synthase expression and intimal thickening. Arterioscler. Thromb. Vasc. Biol. 2000 20 : 1896 902.
27. Maxwell AJ. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 2002 6 : 101 24.
28. Forstermann U, Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch. Pharmacol. 1995 352 : 351 64.
29. Shah V, Wiest R, Garcia-Cardena G, Cadelina G, Groszmann RJ, Sessa WC. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. Am. J. Physiol. 1999 277 : G463 8.
30. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J. Pharmacol. Exp. Ther. 2001 299 : 818 24.
31. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002 35 : 478 91.
32. Kawanaka H, Jones MK, Szabo IL et al. Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-alpha via the PI 3-kinase-Akt signaling pathway. Hepatology 2002 35 : 393 402.